04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
Minority attorneys continue to depart law firms at a higher rate than those in the majority and cont...
Read More >
Welcome! If we have learned anything, 2020 has been an unexpected year. The pandemic has impacted t...
Read More >
In a unanimous decision, the U.S. Supreme Court ruled that Title VII’s charge-filing precondition t...
Read More >
Bicycles, scooters, skates, and skateboards send 50 kids to hospital emergency departments with seri...
Read More >
Fiat Chrysler and France’s PSA Group completed their mega-auto-merger first agreed-to in late 2019,...
Read More >
Most 401(k) plans have an investment policy statement to serve as a blueprint on how and why investm...
Read More >